Gesine Meyer-Rath, MD, PhD
Research Professor
Boston University School of Public Health
Global Health

MD, Freie Universität Berlin
PhD, Freie Universität Berlin



Prof Meyer-Rath is a Research Professor at the Department of Global Health of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV, TB and COVID-19 in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining BUSPH she has worked in the Pediatrics Department of Charité University Hospital Berlin, at the World Health Organization and at the London School of Hygiene and Tropical Medicine.

Prof Meyer-Rath is based in Johannesburg where she works at the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between Boston University and the University of the Witwatersrand. She holds a PhD in Health Economics from the London School of Hygiene and Tropical Medicine as well as a MD/PhD in Physiology from Free University Berlin.


Modeling to support HIV and TB policy in SA
09/04/2024 - 04/30/2027 (Subcontract PI)
University of Cape Town Bill & Melinda Gates


HIV and TB estimation, mathematical modelling, and economic analysis to support national and sub-national HIV policy setting in South Africa
09/30/2020 - 07/31/2024 (Subcontract PI)
University of Cape Town Bill & Melinda Gates


To Support a consortium of modelers to inform the planning of HIV programs in Sub-Saharan Africa to understand the impact of current and future interventions
10/01/2021 - 09/30/2023 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates


COVID-19 priority vaccine modelling for South Africa and beyond
08/12/2021 - 01/31/2023 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates


Rapid Screening for Complex Chronic Conditions (Taxi Rank project)
07/01/2021 - 11/30/2022 (Multi-PI)
PI: Gesine Meyer-Rath, MD, PhD
Foundation for Innovative New Diagnostics (FIND)


Economic Impact of HIV Policy Briefs
11/14/2019 - 04/30/2022 (PI)
Bill and Melinda Gates Foundation


Enhancing the evidence-base for HIV self-testing in young men
04/17/2018 - 12/31/2020 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates


Prospective costing exercises for HIV in high prevalence countries
01/01/2020 - 10/30/2020 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School Bill & Melinda Gates


Identifying optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa
09/01/2016 - 07/31/2017 (Subcontract PI)
Imperial College Bill & Melinda Gates




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bezuidenhout C, Long L, Nichols B, Meyer-Rath G, Fox MP, Theron G, Fourie B, Olifant S, Penn-Nicholson A, Ruhwald M, Medina-Marino A. Sputum and Tongue Swab Molecular Testing for the In-Home Diagnosis of Tuberculosis in Unselected Household Contacts: A Cost and Cost-Effectiveness Analysis. Clin Infect Dis. 2026 Feb 09; 82(1):49-57.View Related Profiles. PMID: 40705837; DOI: 10.1093/cid/ciaf389;
     
  2. Jamieson L, Rosen S, Meyer-Rath G, Mokhele I, Musakwa N, Imai-Eaton JW, Reed DM, Apollo T, Uetela DM, Shodell D, Ehrenkranz P, Fox MP. Age, sex-and what else? Rethinking priorities to close gaps in the HIV care cascade. J Int AIDS Soc. 2026 Feb; 29(2):e70080.View Related Profiles. PMID: 41664349; PMCID: PMC12886747; DOI: 10.1002/jia2.70080;
     
  3. Edoka I, Silal S, Jamieson L, Meyer-Rath G. Corrigendum to "A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme" [Vaccine 42(20) (2024) 125988. Vaccine. 2026 Feb 27; 74:128162. PMID: 41505871
     
  4. Kusemererwa S, Nayiga B, Lebina L, Bekker LG, Philips A, Matharu LB, Govindasamy D, Meyer-Rath G, Kimbugwe G, Ruzagira E, Shahmanesh M, Seeley J, Webb EL, Fox J. Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN). Trials. 2025 Nov 10; 26(1):486. PMID: 41214706; PMCID: PMC12604281; DOI: 10.1186/s13063-025-09138-5;
     
  5. Vesga JF, Mohamed MS, Shandal M, Jabbour E, Lomtadze N, Kubjane M, Trajman A, Meyer-Rath G, Avaliani Z, Rotich W, Mwai D, Croda J, Mathema HT, Kathure I, Pola R, Costa FD, Ndjeka NO, Danelia M, Tonini ML, Solomonia N, Pelissari DM, Falzon D, Miller C, Baena IG, Arinaminpathy N, Schwartzman K, Den Boon S, Campbell JR. The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study. Lancet Glob Health. 2025 Nov; 13(11):e1857-e1868. PMID: 41109257
     
  6. Meyer-Rath G, Jamieson L, Mudimu E, Snyman K, Ong JJ, Corlis J, Warren M, Wiseman V, Kripke K, Barnabas R, Phillips A, Head J, Stenberg K, Sully EA. Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets. Lancet. 2025 Nov 01; 406(10515):2152-2167. PMID: 41176394
     
  7. van Schalkwyk C, Meyer-Rath G, Masuku S, Jamieson L, Bloem P, Rangaraj A, Chidarikire T, Dlamini-Nqeteko S, Doherty M, Johnson LF, Dalal S. Corrigendum to "Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa" [Vaccine 64 (2025) 127770]. Vaccine. 2025 Oct 24; 65:127797. PMID: 41045635
     
  8. Stover J, Sonneveldt E, Tam Y, Horton KC, Phillips AN, Smith J, Martin-Hughes R, Ten Brink D, Citron DT, Kim HY, Akullian A, Mudimu E, Pickles M, Bershteyn A, Williamson J, Meyer-Rath G, Jamieson L, Sully EA, White JN, Heaton A, Clark RA, Tong H, Richards AS, McQuaid CF, Houben RMGJ, White RG, Dimitrov D, Kaftan D. Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health: a modelling study. Lancet Glob Health. 2025 Oct; 13(10):e1669-e1680. PMID: 40975076; PMCID: PMC12447089; DOI: 10.1016/S2214-109X(25)00281-5;
     
  9. van Schalkwyk C, Meyer-Rath G, Masuku S, Jamieson L, Bloem P, Rangaraj A, Chidarikire T, Dlamini-Nqeteko S, Doherty M, Johnson LF, Dalal S. Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa. Vaccine. 2025 Oct 03; 64:127770. PMID: 40992075
     
  10. Bezuidenhout C, Long L, Nichols B, Meyer-Rath G, Fox MP, Olifant S, Theron G, Fiphaza K, Pieruccini M, Ruhwald M, Penn-Nicholson A, Fourie B, Medina-Marino A. Using sputum and tongue swab specimens for in-home point-of-care targeted universal testing for tuberculosis of household contacts: an acceptability and feasibility analysis. BMJ Glob Health. 2025 Aug 21; 10(8).View Related Profiles. PMID: 40840972; PMCID: PMC12374641; DOI: 10.1136/bmjgh-2024-018131;
     
Showing 10 of 106 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 106 publications over 19 distinct years, with a maximum of 13 publications in 2023

YearPublications
20031
20073
20092
20111
20126
20137
20143
20152
20164
20177
20183
20195
20203
202112
20229
202313
202411
202511
20263


2010 International AIDS Society/ ANRS: Young Investigator Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HIV, economic evaluation, costs, investment case, antiretroviral treatment
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Meyer-Rath's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department